Given that BCL2 is a key anti-apoptotic gene [39] and was the most frequently mutated gene in HLT cancer samples, these convergent transitions suggest that HLT cancers might acquire the function of evading apoptosis in a unique way, mutation of the key anti-apoptotic gene BCL2 next to the mutations of certain tumor-suppressor genes. This evidence concerns the gene BCL2 and cancer.